The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to the BSE.
The firm's consolidated net income from operations stood at Rs 1,154 crore for the quarter under consideration as against Rs 1,225 crore for the same period a year ago.
The consolidated net profit of the company, however, rose to Rs 751 crore for the financial year ended March 31, 2015 from Rs 664 crore in the year-ago period.
Meanwhile, in a separate filing, Torrent Pharmaceuticals said its Board of Directors has recommended a final dividend of Rs 6.25 per equity share of Rs 5 each, fully paid up further to the interim dividend of Rs 5 per equity share paid during the last quarter.
Torrent Pharmaceuticals shares closed 0.11 per cent up at Rs 1,256.55 per scrip on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
